Lowey Dannenberg, P.C. is Investigating Aardvark Therapeutics, Inc. (NASDAQ: AARD) for Potential Violations of the Federal Securities Laws
Globe Newswire•18/09/2026•10:55 ET
0
Get started
Create a free account to read the full story and Whiz Insights.